Research Article

Extended Inflammation Parameters (EIP) as Markers of Immune System Cell Activation in Psoriasis

Table 2

Descriptive characteristics of parameters belonging to the EIP group in the study groups and the control group.

Tested parameterGroupNAverageMedianMinMaxSD

1.NEUT-RI (FI)Control group3044.0143.5040.3050.102.10
A group of patients with plaque psoriasis2551.2851.7041.8059.705.45
A group of patients with psoriatic arthritis646.8045.9039.2054.805.96

2.NEUT-GI (SI)Control group30146.68146.20137.80157.004.25
A group of patients with plaque psoriasis25151.44152.10144.20158.403.52
A group of patients with psoriatic arthritis6150.42149.85142.10159.706.21

3.RE-LYMPH (103/μl)Control group300.040.030.010.080.02
A group of patients with plaque psoriasis250.290.280.050.980.22
A group of patients with psoriatic arthritis60.150.150.040.340.12

4.AS-LYMPH (103/μl)Control group300.000.000.000.000.00
A group of patients with plaque psoriasis250.000.000.000.000.00
A group of patients with psoriatic arthritis60.0010.000.000.040.02

N: the number of all variables; SD: standard deviation; NEUT-GI: neutrophil granularity intensity; NEUT-RI: neutrophil reactive intensity; RE-LYMPH: reactive lymphocytes; AS-LYMPH: antibody-secreting reactive lymphocytes.